POLYETHYLENE GLYCOL BASED PRODRUG OF ADRENOMEDULLIN AND USE THEREOF

The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GRIEBENOW, NILS, FLAMME, INGO, KNORR, ANDREAS, MARLEY, JULY, SCHOHE-LOOP, RUDOLF, WITTROCK, SVEN, WUNDER, FRANK, PRITCHARD, IAIN, KOELLNBERGER, MARIA, KOBBERLING, JOHANNES, REDLICH, GORDEN, LERCHEN, HANS-GEORG
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders. La présente invention concerne un nouveau promédicament de l'adrénomédulline à base de polyéthylène glycol (PEG), des procédés pour le préparer, son utilisation pour le traitement et/ou la prévention de maladies, et son utilisation pour la production de médicaments destinés au traitement et/ou à la prévention de maladies, notamment des troubles cardiovasculaires, démateux et/ou inflammatoires.